Get Fit Bharat

Tag: Personal

HomePersonal

The Hanseatic City on the Weser is jam packed with a variety of different experiences. Once again in 2025, the calendar is chock-a-block with all sorts of exciting events. We have put together a small selection. NEW: City Lights from 03–19 January 2025 The City Lights will be bathing the city centre …

Zug, Switzerland:    Three-month interim data from first-of-its-kind trial demonstrate that the combination of Sculptra® and Restylane® Lyft™ or Contour™ effectively improved the facial aesthetic appearance of patients experiencing medication-driven weight loss with associated facial volume loss1 A six-month extension study is ongoing to capture the combined and sustained effects …

Pune, Maharashtra, India Following the traditions of ushering the New Year with happiness and prosperity, CREDAI-Pune Metro’s marks its 23rd edition of its Flagship event and Annual Property Exhibition, “Pune Property Expo 2025”, scheduled to be held from 17th to 19th January 2025 at the Agriculture College Ground, Pune. The event will bring …

New York, United States:  Starr announced that Peter Hirs has been named the company’s chief financial officer, effective January 13, succeeding Howard I. Smith, who is retiring after more than 40 years at Starr and related entities.   This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250113071409/en/   …

PopVax, an Indian full-stack biotechnology company developing broadly-protective mRNA vaccines using machine learning-enabled computational protein design, is delighted to announce that it has been awarded $2 million by the United States Biomedical Advanced Research and Development Authority (BARDA) as one of the winners of the Concept Stage of BARDA’s Patch Forward Prize for its seasonal …

Stock Exchange Release 13.01.2025 at 18:30 EET/EEST   FISKARS CORPORATION: ACQUISITION OF OWN SHARES 13.01.2025   Date 13.01.2025   Exchange transaction Buy   Share class FSKRS   Amount  2000   Average price/share 14.5861 EUR Highest price/share 14.6200 EUR Lowest price/share 14.5000 EUR Total price 29,172.20 EUR       The …

Stockholm, January 14, 2025 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announced that the U.S. Food and Drug Administration (FDA) has accepted BioArctic’s partner Eisai’s Biologics License Application (BLA) for Leqembi subcutaneous autoinjector (SC-AI) for weekly maintenance dosingLeqembi is indicated for the treatment of Alzheimer’s disease (AD) in patients …